Dataset Viewer
Auto-converted to Parquet
Season
stringclasses
3 values
Week
int64
202k
202k
Virus
stringclasses
3 values
Region
stringclasses
11 values
Age Group
stringclasses
7 values
Number Positive
int64
0
6.5k
Number Tested
int64
0
12.9k
Percent Positive
float64
0
100
2021-22
202,147
SARS-CoV-2
Region 2
0-4 years
0
7
0
2021-22
202,147
SARS-CoV-2
Region 2
5-17 years
0
6
0
2021-22
202,147
SARS-CoV-2
Region 2
18-24 years
2
24
8.33
2021-22
202,147
SARS-CoV-2
Region 2
25-49 years
22
125
17.6
2021-22
202,147
SARS-CoV-2
Region 2
50-64 years
32
104
30.77
2021-22
202,147
SARS-CoV-2
Region 2
65+ years
19
100
19
2021-22
202,147
SARS-CoV-2
Region 3
0-4 years
13
67
19.4
2021-22
202,147
SARS-CoV-2
Region 3
5-17 years
9
28
32.14
2021-22
202,147
SARS-CoV-2
Region 3
18-24 years
2
16
12.5
2021-22
202,147
SARS-CoV-2
Region 3
25-49 years
18
56
32.14
2021-22
202,147
SARS-CoV-2
Region 3
50-64 years
24
68
35.29
2021-22
202,147
SARS-CoV-2
Region 3
65+ years
26
104
25
2021-22
202,147
SARS-CoV-2
Region 5
0-4 years
0
1
0
2021-22
202,147
SARS-CoV-2
Region 5
5-17 years
1
3
33.33
2021-22
202,147
SARS-CoV-2
Region 5
18-24 years
5
16
31.25
2021-22
202,147
SARS-CoV-2
Region 5
25-49 years
22
44
50
2021-22
202,147
SARS-CoV-2
Region 5
50-64 years
15
32
46.88
2021-22
202,147
SARS-CoV-2
Region 5
65+ years
13
31
41.94
2021-22
202,147
SARS-CoV-2
Region 6
0-4 years
0
5
0
2021-22
202,147
SARS-CoV-2
Region 6
5-17 years
1
2
50
2021-22
202,147
SARS-CoV-2
Region 6
18-24 years
3
12
25
2021-22
202,147
SARS-CoV-2
Region 6
25-49 years
11
59
18.64
2021-22
202,147
SARS-CoV-2
Region 6
50-64 years
4
49
8.16
2021-22
202,147
SARS-CoV-2
Region 6
65+ years
2
39
5.13
2021-22
202,147
SARS-CoV-2
Region 8
0-4 years
42
681
6.17
2021-22
202,147
SARS-CoV-2
Region 8
5-17 years
50
301
16.61
2021-22
202,147
SARS-CoV-2
Region 8
18-24 years
46
203
22.66
2021-22
202,147
SARS-CoV-2
Region 8
25-49 years
290
695
41.73
2021-22
202,147
SARS-CoV-2
Region 8
50-64 years
152
416
36.54
2021-22
202,147
SARS-CoV-2
Region 8
65+ years
213
623
34.19
2021-22
202,147
SARS-CoV-2
Region 9
0-4 years
0
1
0
2021-22
202,147
SARS-CoV-2
Region 9
5-17 years
0
0
0
2021-22
202,147
SARS-CoV-2
Region 9
18-24 years
0
1
0
2021-22
202,147
SARS-CoV-2
Region 9
25-49 years
0
2
0
2021-22
202,147
SARS-CoV-2
Region 9
50-64 years
0
0
0
2021-22
202,147
SARS-CoV-2
Region 9
65+ years
0
3
0
2021-22
202,147
Influenza
Region 2
0-4 years
0
7
0
2021-22
202,147
Influenza
Region 2
5-17 years
0
4
0
2021-22
202,147
Influenza
Region 2
18-24 years
5
17
29.41
2021-22
202,147
Influenza
Region 2
25-49 years
2
52
3.85
2021-22
202,147
Influenza
Region 2
50-64 years
0
49
0
2021-22
202,147
Influenza
Region 2
65+ years
0
58
0
2021-22
202,147
Influenza
Region 3
0-4 years
0
65
0
2021-22
202,147
Influenza
Region 3
5-17 years
0
22
0
2021-22
202,147
Influenza
Region 3
18-24 years
4
14
28.57
2021-22
202,147
Influenza
Region 3
25-49 years
2
35
5.71
2021-22
202,147
Influenza
Region 3
50-64 years
1
56
1.79
2021-22
202,147
Influenza
Region 3
65+ years
1
73
1.37
2021-22
202,147
Influenza
Region 5
0-4 years
0
0
0
2021-22
202,147
Influenza
Region 5
5-17 years
0
2
0
2021-22
202,147
Influenza
Region 5
18-24 years
0
7
0
2021-22
202,147
Influenza
Region 5
25-49 years
0
24
0
2021-22
202,147
Influenza
Region 5
50-64 years
0
13
0
2021-22
202,147
Influenza
Region 5
65+ years
0
14
0
2021-22
202,147
Influenza
Region 6
0-4 years
0
5
0
2021-22
202,147
Influenza
Region 6
5-17 years
0
2
0
2021-22
202,147
Influenza
Region 6
18-24 years
1
12
8.33
2021-22
202,147
Influenza
Region 6
25-49 years
1
59
1.69
2021-22
202,147
Influenza
Region 6
50-64 years
0
49
0
2021-22
202,147
Influenza
Region 6
65+ years
1
39
2.56
2021-22
202,147
Influenza
Region 8
0-4 years
2
655
0.31
2021-22
202,147
Influenza
Region 8
5-17 years
2
226
0.88
2021-22
202,147
Influenza
Region 8
18-24 years
5
105
4.76
2021-22
202,147
Influenza
Region 8
25-49 years
2
389
0.51
2021-22
202,147
Influenza
Region 8
50-64 years
2
287
0.7
2021-22
202,147
Influenza
Region 8
65+ years
1
443
0.23
2021-22
202,147
Influenza
Region 9
0-4 years
0
1
0
2021-22
202,147
Influenza
Region 9
5-17 years
0
0
0
2021-22
202,147
Influenza
Region 9
18-24 years
1
1
100
2021-22
202,147
Influenza
Region 9
25-49 years
0
2
0
2021-22
202,147
Influenza
Region 9
50-64 years
0
0
0
2021-22
202,147
Influenza
Region 9
65+ years
0
3
0
2021-22
202,147
RSV
Region 2
0-4 years
2
7
28.57
2021-22
202,147
RSV
Region 2
5-17 years
1
4
25
2021-22
202,147
RSV
Region 2
18-24 years
0
13
0
2021-22
202,147
RSV
Region 2
25-49 years
2
38
5.26
2021-22
202,147
RSV
Region 2
50-64 years
0
25
0
2021-22
202,147
RSV
Region 2
65+ years
3
26
11.54
2021-22
202,147
RSV
Region 3
0-4 years
14
50
28
2021-22
202,147
RSV
Region 3
5-17 years
3
18
16.67
2021-22
202,147
RSV
Region 3
18-24 years
0
10
0
2021-22
202,147
RSV
Region 3
25-49 years
0
22
0
2021-22
202,147
RSV
Region 3
50-64 years
0
38
0
2021-22
202,147
RSV
Region 3
65+ years
2
54
3.7
2021-22
202,147
RSV
Region 5
0-4 years
0
0
0
2021-22
202,147
RSV
Region 5
5-17 years
0
0
0
2021-22
202,147
RSV
Region 5
18-24 years
0
1
0
2021-22
202,147
RSV
Region 5
25-49 years
0
1
0
2021-22
202,147
RSV
Region 5
50-64 years
1
3
33.33
2021-22
202,147
RSV
Region 5
65+ years
0
6
0
2021-22
202,147
RSV
Region 6
0-4 years
2
5
40
2021-22
202,147
RSV
Region 6
5-17 years
0
2
0
2021-22
202,147
RSV
Region 6
18-24 years
1
12
8.33
2021-22
202,147
RSV
Region 6
25-49 years
0
59
0
2021-22
202,147
RSV
Region 6
50-64 years
1
49
2.04
2021-22
202,147
RSV
Region 6
65+ years
2
39
5.13
2021-22
202,147
RSV
Region 8
0-4 years
351
668
52.54
2021-22
202,147
RSV
Region 8
5-17 years
52
206
25.24
2021-22
202,147
RSV
Region 8
18-24 years
12
85
14.12
2021-22
202,147
RSV
Region 8
25-49 years
31
343
9.04
End of preview. Expand in Data Studio

RESP-LENS

Description

During the 2022-23 and 2023-24 respiratory illness seasons, the Respiratory Virus Laboratory Emergency Department Network Surveillance (RESP-LENS) system gathered electronic health record (EHR) data from nearly 100 hospitals associated with 24 participating sites located in 20 states and the District of Columbia. There was at least one site in each of the 10 Health and Human Services (HHS) regions. RESP-LENS collected reports of emergency department (ED) visits for acute respiratory illness (ARI) and corresponding viral testing results for SARS-CoV-2 (the virus that causes COVID-19), influenza (flu), and respiratory syncytial virus (RSV). Sites reported data for an average of approximately 77,000 ED visits weekly, of which 11,000 were associated with ARI and 4,000 of those were in children younger than 18 years. Between May 2023 and August 2024, these data were posted to CDC's RESP-LENS public dashboard, showing number tested, number positive, and percent positive for each of the three viruses mentioned, by virus, region, and age group. Due to budget constraints, RESP-LENS was not funded beyond the end of the 2024 fiscal year. RESP-LENS served as a valuable tool for public health and health care professionals and allowed users to visualize and understand trends in virus circulation, estimate disease burden, respond to outbreaks, and inform decisions and strategies for protecting public health.

Dataset Details

  • Publisher: Centers for Disease Control and Prevention
  • Temporal Coverage: 2022-23 and 2023-24 respiratory illness seasons (2 October 2022 through 31 August 2024; data from last 5 weeks of 2023-24 season not available)
  • Geographic Coverage: 24 sites/health systems with a total of >100 participating hospitals located in 20 states and the District of Columbia
  • Last Modified: 2024-12-26
  • Contact: RESP-LENS ([email protected])

Source

Original data can be found at: https://data.cdc.gov/d/ch5i-63ve

Usage

You can load this dataset using:

from datasets import load_dataset
 dataset = load_dataset('HHS-Official/resp-lens')

License

This dataset is licensed under http://opendefinition.org/licenses/odc-odbl/

Downloads last month
31